These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 24028901

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.
    Bajnok L, Seres I, Varga Z, Jeges S, Peti A, Karanyi Z, Juhasz A, Csongradi E, Mezosi E, Nagy EV, Paragh G.
    Metabolism; 2007 Nov; 56(11):1542-9. PubMed ID: 17950106
    [Abstract] [Full Text] [Related]

  • 4. Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents.
    Torun E, Gökçe S, Ozgen İT, Aydın S, Cesur Y.
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):667-75. PubMed ID: 24706428
    [Abstract] [Full Text] [Related]

  • 5. Positive correlation of paraoxonase 1 (PON1) activity with serum insulin level and HOMA-IR in dementia. A possible advantageous role of PON1 in dementia development.
    Bednarska-Makaruk M, Graban A, Lipczyńska-Łojkowska W, Bochyńska A, Rodo M, Krzywkowski T, Ryglewicz D, Wehr H.
    J Neurol Sci; 2013 Jan 15; 324(1-2):172-5. PubMed ID: 23182497
    [Abstract] [Full Text] [Related]

  • 6. Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels.
    Koncsos P, Seres I, Harangi M, Illyés I, Józsa L, Gönczi F, Bajnok L, Paragh G.
    Pediatr Res; 2010 Mar 15; 67(3):309-13. PubMed ID: 19915520
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Persistent elevation of paraoxonase-1 specific enzyme activity after weight reduction in obese non-diabetic men with metabolic syndrome.
    Liang KW, Lee WJ, Lee IT, Lee WL, Lin SY, Hsu SL, Wan CJ, Yu CY, Tsai IC, Fu CP, Ting CT, Sheu WH.
    Clin Chim Acta; 2011 Sep 18; 412(19-20):1835-41. PubMed ID: 21704607
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Paraoxonase (PON)-1 activity in overweight and obese children and adolescents: association with obesity-related inflammation and oxidative stress.
    Krzystek-Korpacka M, Patryn E, Hotowy K, Czapińska E, Majda J, Kustrzeba-Wójcicka I, Noczyńska A, Gamian A.
    Adv Clin Exp Med; 2013 Sep 18; 22(2):229-36. PubMed ID: 23709379
    [Abstract] [Full Text] [Related]

  • 13. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA.
    Clin Endocrinol (Oxf); 2009 Feb 18; 70(2):221-6. PubMed ID: 18505467
    [Abstract] [Full Text] [Related]

  • 14. Relationship Between Paraoxonase-1 and Butyrylcholinesterase Activities and Nutritional Status in Mexican Children.
    Ramírez-Jiménez R, Martínez-Salazar MF, Almenares-López D, Yáñez-Estrada L, Monroy-Noyola A.
    Metab Syndr Relat Disord; 2018 Mar 18; 16(2):90-96. PubMed ID: 29393817
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women.
    dos Santos RE, Aldrighi JM, Lanz JR, Ferezin PC, Marone MM.
    Gynecol Endocrinol; 2005 Nov 18; 21(5):295-301. PubMed ID: 16373250
    [Abstract] [Full Text] [Related]

  • 17. Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered.
    Torun AN, Vural M, Cece H, Camuzcuoglu H, Toy H, Aksoy N.
    Gynecol Endocrinol; 2011 Dec 18; 27(12):988-92. PubMed ID: 21557696
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Leptin and metabolic syndrome in obese and non-obese children.
    Moreno LA, Pineda I, Rodríguez G, Fleta J, Giner A, Juste MG, Sarría A, Bueno M.
    Horm Metab Res; 2002 Jul 18; 34(7):394-9. PubMed ID: 12189588
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.